Latest News Releases From The Newsroom
Analysts Bullish on SentinelOne, Mobileye Global, Carnival, Leidos Holdings and RenaissanceRe
May 25th, 2023
Raymond James has initiated coverage of SentinelOne, Inc. (NYSE: S) with a Strong Buy rating and set a price target of $25. During pre-market, $S is currently trading at $20.50, displaying an upward trend of $0.62 (+3.12%). Wells Fargo has init. Read more
Best Buy Beats Estimates, GDS Holdings Surprises with Narrowed-Than-Expected Loss, Nano Dimension's Bold Offer to Increase Stake in Stratasys
May 25th, 2023
Best Buy Co., Inc. (NYSE: BBY) has announced its financial results for the first quarter of fiscal year 2024, reporting earnings per share (EPS) of $1.15. This figure surpasses the consensus estimate of $1.11 per share. The company's sales performanc. Read more
Strong Q1 Financial Performances: X Financial, Lizhi, Siyata Mobile; Weibo Beats Estimates
May 25th, 2023
In the first quarter of 2023, X Financial (NYSE: XYF) showcased a strong financial performance, demonstrating its continued growth and success. The company's total net revenue reached an impressive RMB1,004.9 million, marking a year-over-year increas. Read more
Splunk, ePlus and LiveRamp Beat Estimates, Digital Turbine Falls Short
May 24th, 2023
Splunk Inc. (Nasdaq: SPLK), a leading provider of data analytics and monitoring solutions, has released its financial results for the fiscal first quarter of 2024. The company reported non-GAAP earnings per share (EPS) of $0.18, significantly b. Read more
Financial Results Triggering Stock Surges: VNET Group, NVIDIA, Modine Manufacturing, e.l.f. Beauty, Nutanix, Zuora
May 24th, 2023
VNET Group, Inc. (Nasdaq: VNET) has announced its financial results for the first quarter of 2023, exceeding market expectations. The company reported earnings per share (EPS) of $0.06, while the consensus projected a loss of $0.09 per share. This po. Read more
Disappointing Results in Mirati Therapeutics' SAPPHIRE Study and Annexon's ARCHER Trial Lead to Stock Declines
May 24th, 2023
Mirati Therapeutics, Inc. (Nasdaq: MRTX) revealed disappointing news regarding the SAPPHIRE study, as it failed to meet its primary goal of overall survival in the final analysis. The Phase 3 study aimed to assess the effectiveness of sitravatinib, i. Read more
Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.
May 24th, 2023
Washington D.C. / CRWE PRESS RELEASE / May 24, 2023 - In response to the announcement that Boston Scientific Corporation and non-vascular stent manufacturer M.I. Tech Co., Ltd. have terminated their $230 million purchase agreement, Federal. Read more
NVIDIA Down Before Earnings; Textron, Wave Life Sciences and Shopify Downgraded
May 24th, 2023
NVIDIA Corporation (Nasdaq: NVDA) is scheduled to announce its financial results for the first quarter of fiscal-year 2024 on Wednesday after the closing bell. Market participants are eagerly awaiting this announcement to gain insights into the compa. Read more
Enveric Biosciences Soars on EVM201 Series Potential, Immutep Surges on Clinical Trial Findings, Buy Rating for IDEAYA Biosciences
May 24th, 2023
Enveric Biosciences, Inc. (Nasdaq: ENVB) said that has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for another patent application involving its EVM201 Series The soon-to-issue patent, titled "C4-Carbox. Read more
Analysts' Perspective: Palo Alto Networks' PT Raised, Agilent Technologies' PT Lowered
May 24th, 2023
Palo Alto Networks, Inc. (Nasdaq: PANW) has seen a series of upward adjustments in its price target from various financial institutions. Deutsche Bank raised the price target from $210 to $225, Scotiabank increased it from $212 to $222, and Raymond J. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026




Member Login